Edgar Ben-Josef MD
Professor, Radiation Oncology, Perelman School of Medicine
Join to View Full Profile
3400 Civic Center BlvdConcourse LevelPhiladelphia, PA 19104
Phone+1 215-662-2428
Dr. Ben-Josef is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Detroit Medical Center/Wayne State UniversityResidency, Radiation Oncology, 1990 - 1993
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1986
Certifications & Licensure
PA State Medical License 2011 - 2026
MI State Medical License 1992 - 2014
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma Start of enrollment: 2009 Aug 01
- TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
- Join now to see all
Publications & Presentations
PubMed
- Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of 2 Prospective Trials.Grace Lee, Bailey Nelson, Julie Koenig, John P Plastaras, James M Metz
International Journal of Radiation Oncology, Biology, Physics. 2025-01-10 - 2 citationsClinical outcomes and risk stratification in unresectable biliary tract cancers undergoing radiation therapy.Uri Amit, Misra Shagun, John P Plastaras, James M Metz, Thomas B Karasic
Radiation Oncology. 2024-08-01 - 3 citationsProton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer.Uri Amit, Ugur Uslu, Ioannis I Verginadis, Michele M Kim, Seyyedeh Azar Oliaei Motlagh
Proceedings of the National Academy of Sciences of the United States of America. 2024-07-30
Press Mentions
Proton Beam RT Doubled OS in Unresectable Liver CancerNovember 5th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
